Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors

Creative Commons License

KUTLU M., ERGİN Ç., Sen-Turk N., SAYIN KUTLU S., ZORBOZAN O., AKALIN Ş., ...Daha Fazla

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.9, sa.2, ss.141-148, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3855/jidc.5155
  • Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.141-148
  • Anahtar Kelimeler: experimental brucellosis, anti-TNF-alpha drug, etanercept, infliximab, ANTI-TNF-ALPHA, RHEUMATOID-ARTHRITIS, MOUSE MODEL, INFLIXIMAB, ABORTUS, PATIENT, EXPRESSION, HEPATITIS, DISEASE, TOLL-LIKE-RECEPTOR-4
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Introduction: There is limited data in the literature about brucellosis related to an intracellular pathogen and anti-tumor necrosis factor alpha (anti-TNF alpha) medication. The aim of this study was to evaluate acute Brucella infections in mice receiving anti-TNF alpha drug treatment.